TLR7 and breast cancer: Flow cytometric analysis revealed that BC-associated-MDSCs treated with si-STAT3 and TLR7/8 agonist expressed high levels of CD86 and CD11c, which is a sign of M1 polarization, but they expressed low levels of CD206 (Figures 5A–D and Table 2).